Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Hims & Hers posts huge Q1 loss; Doximity emerges as a profitable telehealth alternative.
HIMS
$36.85
-$0.32 -0.86%

Hims & Hers posts huge Q1 loss; Doximity emerges as a profitable telehealth alternative.

Company Fundamentals
18 May 2026
24/7 Wall Street
View Source
Bearish
pluang ai news

Hims & Hers reported a severe Q1 2026 loss with EPS at -$0.40 versus a $0.03 consensus and a net loss of $92.11 million, causing shares to drop 14.1%. The company's U.S. business shrank 8% year-over-year, and liabilities surged 431% to $1.82 billion, raising concerns about its financial health. Meanwhile, Doximity, a physician-focused telehealth platform, showed strong profitability with a 60.2% EBITDA margin and growing user engagement, supported by a $500 million share buyback program. Investors are advised to be cautious with hype-driven stocks like Hims & Hers and consider stable, cash-generating platforms like Doximity for long-term investment.

More News (HIMS)

Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent.

Law firm investigates Hims & Hers for allegedly sharing users' private health data without consent.

Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...

Market News
Bearish
13 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App